Af
Affinia Ther
Waltham MAFounded 201950 employees
Private CapbiotechPrivateRare DiseaseNeurology
Platform: Synth AAV
Market Cap
N/A
All Drugs
3
Clinical Trials
6
Failed / Terminated
1
FDA Approved
1
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Adagracapivasertib | AFF-2604 | Approved | 3 | MALT1 | PompeDravet | ||
| Motavorutinib | AFF-9229 | NDA/BLA | 2 | PRMT5 | WMWet AMD | ||
| AFF-3518 | AFF-3518 | Phase 1 | 1 | HER2 | CeliacALS |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (6)